PTGS2 and schwannoma: Given that recent data, we questioned whether COX-2 inhibition could be used as a chemopreventative strategy in NF2 mediated schwannoma formation, especially in light of the success of inhibition of COX-2 in other cancer predisposition syndromes [7].